ChemoMetec A/S Stock Company Profile

Description

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis in Denmark, the United States, Canada, rest of Europe, and internationally. The company offers automated cell counters and image analyzers, such as NucleoCounter NC-3000, an advanced image cytometer to characterize cell properties; NucleoCounter NC-250, an automated cell analyzer to characterize cell properties; NucleoCounter NC-202, a consistent cell counter; and NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination. It also provides NucleoCounter YC-100, an automated yeast cell counter used to measure the total cell count and viability of yeast cells in suspension; NucleoCounter SP-100, a sperm cell counter that offers total sperm concentration and sperm viability in a semen sample from ejaculates or extended doses; and NucleoCounter SCC-100, a somatic cell counter used to measure the number of somatic cells in a milk sample. In addition, the company offers consumables comprising cassettes, reagents, slides, and test kits; and accessories, which include cables, power supplies, software, and labware products, as well as service plans. The company was founded in 1997 and is headquartered in Allerød, Denmark.